These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17488882)

  • 1. Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats.
    Peterson SJ; Husney D; Kruger AL; Olszanecki R; Ricci F; Rodella LF; Stacchiotti A; Rezzani R; McClung JA; Aronow WS; Ikehara S; Abraham NG
    J Pharmacol Exp Ther; 2007 Aug; 322(2):514-20. PubMed ID: 17488882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes.
    Kruger AL; Peterson S; Turkseven S; Kaminski PM; Zhang FF; Quan S; Wolin MS; Abraham NG
    Circulation; 2005 Jun; 111(23):3126-34. PubMed ID: 15939814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apolipoprotein A-I mimetic peptide, D-4F, alleviates ox-LDL-induced oxidative stress and promotes endothelial repair through the eNOS/HO-1 pathway.
    Liu D; Ding Z; Wu M; Xu W; Qian M; Du Q; Zhang L; Cui Y; Zheng J; Chang H; Huang C; Lin D; Wang Y
    J Mol Cell Cardiol; 2017 Apr; 105():77-88. PubMed ID: 28274624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes.
    Turkseven S; Kruger A; Mingone CJ; Kaminski P; Inaba M; Rodella LF; Ikehara S; Wolin MS; Abraham NG
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H701-7. PubMed ID: 15821039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin.
    Sambuceti G; Morbelli S; Vanella L; Kusmic C; Marini C; Massollo M; Augeri C; Corselli M; Ghersi C; Chiavarina B; Rodella LF; L'Abbate A; Drummond G; Abraham NG; Frassoni F
    Stem Cells; 2009 Feb; 27(2):399-407. PubMed ID: 19038792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
    Rodriguez F; Lopez B; Perez C; Fenoy FJ; Hernandez I; Stec DE; Li Volti G; Salom MG
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1540-8. PubMed ID: 21849637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation.
    Liu D; Wu M; Du Q; Ding Z; Qian M; Tong Z; Xu W; Zhang L; Chang H; Wang Y; Huang C; Lin D
    J Cell Mol Med; 2017 Dec; 21(12):3810-3820. PubMed ID: 28767201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress.
    Zhu J; Wang CG; Xu YG
    Pharm Biol; 2011 Nov; 49(11):1144-9. PubMed ID: 21517710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effect of lixisenatide on diabetic cardiovascular damage and its enhancement via ticagrelor co-administration in rats: possible role of eNOS and NrFâ‚‚ /HO-1 signaling.
    Sleem M; Aboubakr EM; Mohamed WR; Messiha BAS; Taye A
    Pharmazie; 2024 Jun; 79(6):101-108. PubMed ID: 38877681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes.
    Rodella LF; Vanella L; Peterson SJ; Drummond G; Rezzani R; Falck JR; Abraham NG
    Drug Metab Lett; 2008 Dec; 2(4):290-300. PubMed ID: 19356108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway.
    Zhang Z; Qun J; Cao C; Wang J; Li W; Wu Y; Du L; Zhao P; Gong K
    Mol Biol Rep; 2012 Apr; 39(4):4445-54. PubMed ID: 21947883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.
    Thirunavukkarasu M; Penumathsa SV; Koneru S; Juhasz B; Zhan L; Otani H; Bagchi D; Das DK; Maulik N
    Free Radic Biol Med; 2007 Sep; 43(5):720-9. PubMed ID: 17664136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction.
    Kawamura K; Ishikawa K; Wada Y; Kimura S; Matsumoto H; Kohro T; Itabe H; Kodama T; Maruyama Y
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):155-60. PubMed ID: 15499042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
    Zhang W; Yan H
    Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.
    L'Abbate A; Neglia D; Vecoli C; Novelli M; Ottaviano V; Baldi S; Barsacchi R; Paolicchi A; Masiello P; Drummond GS; McClung JA; Abraham NG
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3532-41. PubMed ID: 17906103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats.
    Ahmad M; Turkseven S; Mingone CJ; Gupte SA; Wolin MS; Abraham NG
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):371-6. PubMed ID: 16309587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice.
    Vecoli C; Cao J; Neglia D; Inoue K; Sodhi K; Vanella L; Gabrielson KK; Bedja D; Paolocci N; L'abbate A; Abraham NG
    J Cell Biochem; 2011 Sep; 112(9):2616-26. PubMed ID: 21598304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats.
    Quan S; Kaminski PM; Yang L; Morita T; Inaba M; Ikehara S; Goodman AI; Wolin MS; Abraham NG
    Biochem Biophys Res Commun; 2004 Mar; 315(2):509-16. PubMed ID: 14766238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells.
    Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA
    Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.